Omar Abdel-Wahab
Chair, Molecular Pharmacology Program · Sloan Kettering Institute
Credentials: · · · ·
History
- 2022–Present
Molecular Pharmacology Program Department · Sloan Kettering Institute
2008–2010
2000–2004
Research
Cancer Cell · 2010 · 2,289 citations
Cancer Cell · 2010 · 1,679 citations
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Nature · 2012 · 1,631 citations
103 papers
51 papers
40 papers
36 papers · 17 as a resident
- MT
36 papers
- RR
31 papers · 14 as a fellow
- AD
20 papers
16 papers
Grants
- 2025–2032
Understanding and Targeting Aberrant RNA Splicing in Leukemia
National Cancer Institute · R35
Contact PI · $2M · Sloan-Kettering Inst Can Research
- 2021–2031
The Memorial Sloan Kettering Cancer Center SPORE in Leukemia
National Cancer Institute · P50
Contact PI · $13.8M · Sloan-Kettering Inst Can Research
- 2015–2030
MSK Paul Calabresi Career Development Award for Clinical Oncology
National Cancer Institute · K12
PI · $4.6M · Sloan-Kettering Inst Can Research
- 1977–2029
Investigational Cancer Therapeutics Training Program (ICTTP)
National Cancer Institute · T32
PI · $1.1M · Sloan-Kettering Inst Can Research
Clinical trials
- 2014–2019
Long-term Outcome After Vemurafenib / BRAF Inhibitors Interruption in Erdheim-chester Disease
Sub-investigator · Unknown
Groupe Hospitalier Pitie-Salpetriere